Tissue inhibitor of metalloproteinases (TIMPs) in heart failure (Q37895982)

25 August 2017

1 reference

title

Tissue inhibitor of metalloproteinases (TIMPs) in heart failure (English)

1 reference

25 August 2017

0 references

Linn Moore

1

1 reference

25 August 2017

Dong Fan

2

1 reference

25 August 2017

Ratnadeep Basu

3

1 reference

25 August 2017

Vijay Kandalam

4

1 reference

25 August 2017

Zamaneh Kassiri

5

1 reference

25 August 2017

1 September 2012

1 reference

25 August 2017

Heart Failure Reviews

1 reference

25 August 2017

17

1 reference

25 August 2017

4-5

1 reference

25 August 2017

693-706

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-011-9266-y

25 August 2017

0 references

cites work

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Matrix metalloproteinase therapy in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Integrins and the myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Integrins, membrane-type matrix metalloproteinases and ADAMs: potential implications for cardiac remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Role of the alpha 1 beta 1 integrin complex in collagen gel contraction in vitro by fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Circulating stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Inhibition of membrane-type 1 matrix metalloproteinase at cell-matrix adhesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Interaction of MT1-MMP and laminin-5gamma2 chain correlates with metastasis and invasiveness in human esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: differential expression with collagenase-1 (matrix metalloproteinase-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Expression analysis of the entire MMP and TIMP gene families during mouse tissue development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Tissue inhibitor of metalloproteinases-4. The road less traveled.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Role of metalloproteinases in platelet function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Three-dimensional structure of human tissue inhibitor of metalloproteinases-2 at 2.1 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Computational sequence analysis of the tissue inhibitor of metalloproteinase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Localization of the functional domains of human tissue inhibitor of metalloproteinases-3 and the effects of a Sorsby's fundus dystrophy mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Protein glycosylation in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Plasma monitoring of the myocardial specific tissue inhibitor of metalloproteinase-4 after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Matrix metalloproteinases: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

TIMPs as multifacial proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Individual Timp deficiencies differentially impact pro-MMP-2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP-4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Structural determinants of the ADAM inhibition by TIMP-3: crystal structure of the TACE-N-TIMP-3 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

The regulation of matrix metalloproteinases and their inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial [correction of myoctardial] ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Transforming growth factor Beta1 induction of tissue inhibitor of metalloproteinases 3 in articular chondrocytes is mediated by reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Fibrogenic and inflammatory cytokines modulate mRNA expressions of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-3 in type II pneumocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Atrial extracellular matrix remodelling in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Loss of TIMP3 enhances interstitial nephritis and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

NF-Y and Sp1 cooperate for the transcriptional activation and cAMP response of human tissue inhibitor of metalloproteinases-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Structure and characterization of the human tissue inhibitor of metalloproteinases-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Molecular cloning of mouse tissue inhibitor of metalloproteinases-3 and its promoter. Specific lack of expression in neoplastic JB6 cells may reflect altered gene methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Ribo-gnome: the big world of small RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

The functions of animal microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

TIMP3: a physiological regulator of adult myogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Extracellular matrix fibrotic markers in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Increased circulating matrix metalloproteinase-2 in patients with hypertrophic cardiomyopathy with systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Differential gene expression of extracellular matrix components in dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Filling Pressures and Collagen Metabolism in Hypertensive Patients With Heart Failure and Normal Ejection Fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Mouse models of MMP and TIMP function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

TIMP-2 is required for efficient activation of proMMP-2 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Tissue inhibitor of metalloproteinase-2 gene delivery ameliorates postinfarction cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

TIMP-3 deficiency leads to dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Simultaneous transforming growth factor beta-tumor necrosis factor activation and cross-talk cause aberrant remodeling response and myocardial fibrosis in Timp3-deficient heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Relationship of admission neutrophil count to microvascular injury, left ventricular dilation, and long-term outcome in patients treated with primary angioplasty for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Mice with tissue inhibitor of metalloproteinases 4 (Timp4) deletion succumb to induced myocardial infarction but not to cardiac pressure overload.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Fibronectin fragments containing the RGDS cell-binding domain mediate monocyte migration into the rabbit lung. A potential mechanism for C5 fragment-induced monocyte lung accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Chemotactic activity of elastin-derived peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Fragments of extracellular matrix as mediators of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Monocyte chemotactic activity in human abdominal aortic aneurysms: role of elastin degradation peptides and the 67-kD cell surface elastin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Matrix metalloproteinase-8: cleavage can be decisive

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Clusterin, an abundant serum factor, is a possible negative regulator of MT6-MMP/MMP-25 produced by neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Macrophage roles following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Tissue inhibitor of metalloproteinases 3 regulates resolution of inflammation following acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Novel functions of TIMPs in cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

TIMP-2: an endogenous inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates neuromuscular junction development via a beta1 integrin-mediated mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Endothelial nitric oxide synthase promotes neonatal cardiomyocyte proliferation by inhibiting tissue inhibitor of metalloproteinase-3 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Inhibition of Wilms' tumor growth by intramuscular administration of tissue inhibitor of metalloproteinases-4 plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Extracellular matrix turnover and signaling during cardiac remodeling following MI: causes and consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Extracellular matrix remodeling during the progression of volume overload-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Plasma tissue inhibitor of metalloproteinase-1 levels are elevated in essential hypertension and related to left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Combination of Tumor Necrosis Factor-α Ablation and Matrix Metalloproteinase Inhibition Prevents Heart Failure After Pressure Overload in Tissue Inhibitor of Metalloproteinase-3 Knock-Out Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Abnormal TNF activity in Timp3 −/− mice leads to chronic hepatic inflammation and failure of liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9266-Y

Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study

21 January 2018

1 reference

12 December 2020

TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3

1 reference

12 December 2020

FOXO1A differentially regulates genes of decidualization

1 reference

12 December 2020

TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5)

1 reference

12 December 2020

Preventing adverse remodeling and rupture during healing after myocardial infarction in mice and humans

1 reference

12 December 2020

Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation

1 reference

12 December 2020

Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy

1 reference

12 December 2020

Differential expression of tissue inhibitors of metalloproteinases in the failing human heart

1 reference

12 December 2020

Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice

1 reference

12 December 2020

Glycosylation and NH2-terminal domain mutants of the tissue inhibitor of metalloproteinases-1 (TIMP-1)

1 reference

12 December 2020

Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats

1 reference

12 December 2020

Rate of collagen deposition during healing and ventricular remodeling after myocardial infarction in rat and dog models

1 reference

12 December 2020

Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart

1 reference

12 December 2020

Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction

1 reference

12 December 2020

Human fibroblast collagenase-alpha-macroglobulin interactions. Localization of cleavage sites in the bait regions of five mammalian alpha-macroglobulins

1 reference

12 December 2020

Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation

1 reference

12 December 2020

Erythropoietin induction of tissue inhibitors of metalloproteinase-1 expression and secretion is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways.

1 reference

12 December 2020

Myocardial extra-cellular matrix and its regulation by metalloproteinases and their inhibitors

1 reference

12 December 2020

The prognostic value of circulating markers of collagen turnover after acute myocardial infarction

1 reference

12 December 2020

Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism

1 reference

12 December 2020

TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation

1 reference

12 December 2020

Usefulness of plasma tissue inhibitors of metalloproteinases as markers of prognosis after acute myocardial infarction

1 reference

12 December 2020

Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress

1 reference

12 December 2020

Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: effects of exogenous MMP inhibition

1 reference

12 December 2020

Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice

1 reference

12 December 2020

Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase

1 reference

12 December 2020

Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling

1 reference

12 December 2020

Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.

1 reference

12 December 2020

Identification of an initiator-like element essential for the expression of the tissue inhibitor of metalloproteinases-4 (Timp-4) gene.

1 reference

12 December 2020

1 reference

12 December 2020

Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080.

1 reference

12 December 2020

Biophysical and functional characterization of full-length, recombinant human tissue inhibitor of metalloproteinases-2 (TIMP-2) produced in Escherichia coli. Comparison of wild type and amino-terminal alanine appended variant with implications for t

1 reference

12 December 2020

TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy.

1 reference

12 December 2020

Tissue inhibitor of metalloproteinase-4 instigates apoptosis in transformed cardiac fibroblasts

1 reference

12 December 2020

Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment

1 reference

12 December 2020

Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds

1 reference

12 December 2020

10.1007/S10741-011-9266-Y

Identifiers

DOI

1 reference

release_wlzpjogujba5rd3cjsyjq7xzim

25 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wlzpjogujba5rd3cjsyjq7xzim

24 November 2022

mapped directly with Wikidata item

1 reference